Form 8-K - Current report:
SEC Accession No. 0000805928-25-000140
Filing Date
2025-12-04
Accepted
2025-12-03 20:03:08
Documents
14
Period of Report
2025-12-03
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K axgn-20251203.htm   iXBRL 8-K 31533
2 EX-99.1 - PRESS RELEASE ex991axgnpressreleasedated.htm EX-99.1 17267
6 AXGN LOGO image_0a.jpg GRAPHIC 30876
  Complete submission text file 0000805928-25-000140.txt   213096

Data Files

Seq Description Document Type Size
3 IXBRL TAXONOMY EXTENSION SCHEMA DOCUMENT axgn-20251203.xsd EX-101.SCH 1788
4 IXBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT axgn-20251203_lab.xml EX-101.LAB 21629
5 IXBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT axgn-20251203_pre.xml EX-101.PRE 12512
16 EXTRACTED XBRL INSTANCE DOCUMENT axgn-20251203_htm.xml XML 3000
Mailing Address 13631 PROGRESS BLVD. SUITE 400 ALACHUA FL 32615
Business Address 13631 PROGRESS BLVD. SUITE 400 ALACHUA FL 32615 (386) 462-6817
Axogen, Inc. (Filer) CIK: 0000805928 (see all company filings)

EIN.: 411301878 | State of Incorp.: MN | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36046 | Film No.: 251547938
SIC: 3845 Electromedical & Electrotherapeutic Apparatus
(CF Office: 08 Industrial Applications and Services)